KSF News, Updates, & Insights

Final Approval of $4.8 Million Settlement Granted in Orexigen Securities Litigation

On October 28, 2021, the Hon. Janis Lynn Sammartino, United States District Court Judge for the Southern District of California, granted final approval to the class action settlement in Khoja v. Orexigen Therapeutics, Inc., et al., No. 3:15-cv-00540-JLS-AGS, approving Lead Plaintiff’s $4.8 million recovery for investors. In her subsequent written opinion approving the settlement, the Court highlighted the “significant results for the Settlement Class,” noting KSF’s “significant skill and extensive work” and that the “settlement may not have been reached without Lead Counsel’s skill and expertise.”